Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05518617 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Molecular and Functional Imaging in Monogenic PD.

Study acronym: FOX_1
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 7, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Jun 30, 2025 to Jun 30, 2026
    • Study arms: 3 to 4
    v4
  2. Primary and study completion dates: Jun 30, 2024 to Jun 30, 2025v3
  3. Primary and study completion dates: Apr 1, 2024 to Jun 30, 2024v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study, the investigators aim to find a biomarker of Parkinson's disease. This is done using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI). The findings will provide a deeper understanding of the brain changes in Parkinson's disease. More importantly, this study will help with the discovery and development of new medications aiming to delay progression of PD symptoms.
Trial Details
NCT Number NCT05518617
Lead Sponsor University of Exeter
Conditions
(from sponsor)		 Parkinson Disease, Nervous System Disorder, Neurodegenerative Diseases, Neurodegenerative Disease, Hereditary, Parkinson's
Related terms Heredodegenerative Disorders, Nervous System, Nervous System Diseases, Neurodegenerative Diseases, Parkinson Disease
Enrollment 45 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov